{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:35:37Z","timestamp":1789076137596,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajic.2025.01.017","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:05:39Z","timestamp":1738224339000},"page":"612-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluoroquinolone consumption and resistance after an Antibiotic Stewardship Team intervention\u2014An interventional study in a single hospital in Southern Poland from 2018 to\u00a02023"],"prefix":"10.1016","volume":"53","author":[{"given":"P.","family":"Serwacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hareza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"\u015awi\u0105tek-Kwapniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Adamowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Serwacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wa\u0142aszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"W\u00f3jkowska-Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2025.01.017_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2383-z","article-title":"Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis","volume":"17","author":"Zilberberg","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2025.01.017_bib2","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2165\/00003495-200363200-00001","article-title":"Appropriate empirical antibacterial therapy for nosocomial infections","volume":"63","author":"Kollef","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ajic.2025.01.017_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.rmed.2003.12.006","article-title":"Non-infectious and unusual infectious mimics of community-acquired pneumonia","volume":"98","author":"Alves dos Santos","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.ajic.2025.01.017_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18683\/germs.2020.1230","article-title":"When antibiotics experts say no to antibiotics","volume":"10","author":"Thabit","year":"2020","journal-title":"Germs"},{"key":"10.1016\/j.ajic.2025.01.017_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106184","article-title":"Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections","volume":"56","author":"Bassetti","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2025.01.017_bib6","first-page":"e51","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin\u00a0Infect\u00a0Dis"},{"issue":"9","key":"10.1016\/j.ajic.2025.01.017_bib7","first-page":"1","article-title":"Antibiotic resistance: challenges and strategies in combating infections","volume":"15","author":"Chavada","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ajic.2025.01.017_bib8","unstructured":"CDC. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA: US Department of Health and Human Services, CDC 2019. Accessed January 23, 2024.\u00a0https:\/\/www.cdc.gov\/antibiotic-use\/core-elements\/hospital.html."},{"key":"10.1016\/j.ajic.2025.01.017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11091193","article-title":"Tissue penetration of antimicrobials in intensive care unit patients: a systematic review\u2014part II","volume":"11","author":"Viaggi","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2025.01.017_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/00003495-200565070-00004","article-title":"Guide to selection of fluoroquinolones in patients with lower respiratory tract infections","volume":"65","author":"Shams","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ajic.2025.01.017_bib11","unstructured":"European Association of Urology. EAU urological infections guidelines; 2023. Accessed March 27, 2024.\u00a0https:\/\/uroweb.org\/guidelines\/urological-infections."},{"issue":"268","key":"10.1016\/j.ajic.2025.01.017_bib12","first-page":"1","article-title":"The current case of quinolones: synthetic approaches and antibacterial activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ajic.2025.01.017_bib13","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2021. Stockholm: ECDC; 2022. Accessed December 7, 2023.\u00a0https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER-EARS-Net-2021_2022-final.pdf."},{"key":"10.1016\/j.ajic.2025.01.017_bib14","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects;\u00a02016. Accessed\u00a0January 23, 2024.\u00a0https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics."},{"key":"10.1016\/j.ajic.2025.01.017_bib15","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"\u201cCollateral damage\u201d from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2025.01.017_bib16","unstructured":"European Medicines Agency. Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects; 2023. Accessed January 23, 2024.\u00a0https:\/\/www.ema.europa.eu\/en\/news\/fluoroquinolone-antibiotics-reminder-measures-reduce-risk-long-lasting-disabling-and-potentially-irreversible-side-effects."},{"key":"10.1016\/j.ajic.2025.01.017_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph15010112","article-title":"Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: a 10 year observation in a Provincial Hospital in Southern Poland","volume":"15","author":"Ko\u0142pa","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2025.01.017_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph18052238","article-title":"The incidence of healthcare-associated infections, their clinical forms, and microbiological agents in intensive care units in Southern Poland in a multicentre study from 2016 to 2019","volume":"18","author":"Rafa","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2025.01.017_bib19","first-page":"715","article-title":"Hospital antibiotic consumption\u2014an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study","volume":"75","author":"Siewierska","year":"2023","journal-title":"Pharmacol\u00a0Rep"},{"key":"10.1016\/j.ajic.2025.01.017_bib20","first-page":"230","article-title":"COVID-19 and antibiotic consumption in the intensive care units of the Polish tertiary hospital","volume":"145","author":"W\u00f3jkowska-Mach","year":"2024","journal-title":"J\u00a0Hosp\u00a0Infect"},{"key":"10.1016\/j.ajic.2025.01.017_bib21","unstructured":"World Health Organization. The ATC\/DDD methodology; 2023. Accessed January 23, 2024.\u00a0https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/methodology."},{"key":"10.1016\/j.ajic.2025.01.017_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00210-023-02622-2","article-title":"Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU\/EEA countries between 2016 and 2021","volume":"397","author":"Serwacki","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ajic.2025.01.017_bib23","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals \u2013 ECDC PPS validation protocol version 3.1.2. Stockholm: 2019."},{"key":"10.1016\/j.ajic.2025.01.017_bib24","unstructured":"EUCAST. Clinical breakpoints - breakpoints and guidance; n.d. Accessed June 2, 2024. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_14.0_Breakpoint_Tables.pdf."},{"key":"10.1016\/j.ajic.2025.01.017_bib25","unstructured":"European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases; 2023.\u00a0Accessed June 2, 2024. https:\/\/www.ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases."},{"key":"10.1016\/j.ajic.2025.01.017_bib26","first-page":"211","article-title":"Measurement of adult antimicrobial drug use in tertiary care hospital using defined daily dose and days of therapy","volume":"76","author":"Bansal","year":"2014","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.ajic.2025.01.017_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2125.2006.02605.x","article-title":"Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital","volume":"61","author":"Muller","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajic.2025.01.017_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211011876","article-title":"Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital","volume":"104","author":"Zeana","year":"2021","journal-title":"Sci Prog"},{"issue":"4","key":"10.1016\/j.ajic.2025.01.017_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofab070","article-title":"The effect of antibiotic restriction programs on prevalence of antimicrobial resistance: a systematic review and meta-analysis","volume":"8","author":"Schuts","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2025.01.017_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/trstmh\/traa041","article-title":"Molecular mechanisms associated with quinolone resistance in Enterobacteriaceae: review and update","volume":"114","author":"Azargun","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ajic.2025.01.017_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.680975","article-title":"Impact of social, economic, and healthcare factors on the regional structure of antibiotic consumption in primary care in Poland (2013\u20132017)","volume":"9","author":"Olczak-Pie\u0144kowska","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.ajic.2025.01.017_bib32","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption dashboard (ESAC-Net); 2023.\u00a0Accessed January 31, 2024.\u00a0https:\/\/qap.ecdc.europa.eu\/public\/extensions\/AMC2_Dashboard\/AMC2_Dashboard.html#eu-consumption-tab."},{"key":"10.1016\/j.ajic.2025.01.017_bib33","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"61","author":"Martin-Loeches","year":"2023","journal-title":"Eur\u00a0Respir\u00a0J"},{"key":"10.1016\/j.ajic.2025.01.017_bib34","unstructured":"\u017bukowska A, Hryniewicz W.Rekomendacje diagnostyki, terapii i profilaktyki antybiotykowej zaka\u017ce\u0144 w szpitalu \u2013 2020. 2020."},{"key":"10.1016\/j.ajic.2025.01.017_bib35","unstructured":"National Institute for Health and Care Excellence. Pneumonia (community-acquired): antimicrobial prescribing; 2019.\u00a0Accessed June 12, 2024.\u00a0https:\/\/www.nice.org.uk\/guidance\/ng138."},{"key":"10.1016\/j.ajic.2025.01.017_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ofid\/ofv133.959","article-title":"Antimicrobial restriction and preauthorization: easier said than done?","volume":"2","author":"Jen","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2025.01.017_bib37","first-page":"1457","article-title":"Thinking beyond the \u201ccore\u201d antibiotic stewardship interventions: shifting the onus for appropriate antibiotic use from stewardship teams to prescribing clinicians","volume":"72","author":"Jenkins","year":"2021","journal-title":"Clin\u00a0Infect\u00a0Dis"},{"issue":"10","key":"10.1016\/j.ajic.2025.01.017_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics12101522","article-title":"The interventions and challenges of antimicrobial stewardship in the emergency department","volume":"12","author":"Ruiz-Ramos","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2025.01.017_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40506-021-00256-7","article-title":"The emerging role of telehealth in antimicrobial stewardship: a systematic review and perspective","volume":"13","author":"Pierce","year":"2021","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1016\/j.ajic.2025.01.017_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/14787210.2023.2285425","article-title":"Impact of a multidisciplinary antimicrobial stewardship program on antibiotic utilization and clinical outcomes at a tertiary hospital in Saudi Arabia: a quasi-experimental study","volume":"22","author":"Sarkhi","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ajic.2025.01.017_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/viru.21626","article-title":"Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes","volume":"4","author":"Chung","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ajic.2025.01.017_bib42","first-page":"1828","article-title":"The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews","volume":"77","author":"Van Dort","year":"2022","journal-title":"J\u00a0Antimicrob\u00a0Chemother"},{"key":"10.1016\/j.ajic.2025.01.017_bib43","first-page":"608","article-title":"Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting","volume":"62","author":"Buising","year":"2008","journal-title":"J\u00a0Antimicrob\u00a0Chemother"},{"key":"10.1016\/j.ajic.2025.01.017_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-021-00450-x","article-title":"Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia","volume":"20","author":"Alhumaid","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655325000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655325000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:32:00Z","timestamp":1745933520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655325000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0196655325000483"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2025.01.017","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone consumption and resistance after an Antibiotic Stewardship Team intervention\u2014An interventional study in a single hospital in Southern Poland from 2018 to\u00a02023","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2025.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}